Masteron Maste200 – Drostanolone Enanthate 200mg/ml
Sustained Muscle Hardness, Definition & Cutting Power
Why Choose Masteron Maste200?
Masteron Maste200 (Drostanolone Enanthate) is a long-acting anabolic compound designed for athletes and bodybuilders seeking a defined, lean, and aesthetic physique. Unlike the fast-acting Propionate version, the Enanthate ester delivers slower, sustained release, requiring fewer injections while maintaining stable blood levels.
Known for its drying, hardening, and anti-estrogenic properties, Maste200 is a staple in cutting cycles and contest preparation. It helps athletes achieve a dense, vascular look while supporting fat loss and performance.
🔬 Product Details
- Compound: Drostanolone Enanthate (Masteron)
- Strength: 200mg/ml
- Form: Injectable, long ester
- Best For: Cutting, hardening, and physique detailing
- Recommended Dosage: 400–600mg per week
- Cycle Length: 8–12 weeks
⚡ Key Benefits
- Promotes muscle hardness, density, and definition
- Long-acting ester = fewer injections compared to Propionate
- Enhances vascularity and lean, dry appearance
- Supports fat loss and metabolic efficiency
- Does not convert to estrogen → no water retention or bloating
- Complements Testosterone, Trenbolone, or Primobolan in advanced stacks
📌 Expert Insight
Reviewed by Dr. Aaron, PhD, specialist in performance pharmacology. Drostanolone Enanthate is praised for its ability to maintain a competition-ready physique while minimizing estrogenic side effects, making it ideal for long-term cutting cycles.
📦 Shipping & Service
- Global delivery via UPS, FedEx, USPS
- Processing time: 3 business days
- Estimated arrival: 7–10 days
- All packages are insured & discreet
- Free worldwide shipping on orders of 5+ items
⚠️ Medical & Legal Disclaimer
This product is intended for research or prescription use only. Not approved for casual or unsupervised human use. Always consult a licensed medical professional before use and follow all applicable laws in your region.












Reviews
There are no reviews yet.